| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0004600 | Exon-Exon | chr6:146209156-146256577 | chr6:145888020-145935441 | 2398 nt | 0.4358 |
| hsa_SHPRH_0004700 | Exon-Exon | chr6:146209156-146261937 | chr6:145888020-145940801 | 2477 nt | 0.4380 |
| hsa_SHPRH_0004800 | Exon-Exon | chr6:146209156-146276490 | chr6:145888020-145955354 | 250 nt | 0.3440 |
| hsa_SHPRH_0006200 | Exon-Exon | chr6:146214351-146216113 | chr6:145893215-145894977 | 359 nt | 0.4345 |
| hsa_SHPRH_0006300 | Exon-Exon | chr6:146214351-146273614 | chr6:145893215-145952478 | 250 nt | 0.3400 |
| hsa_SHPRH_0006700 | Exon-Exon | chr6:146215286-146216113 | chr6:145894150-145894977 | 180 nt | 0.4056 |
| hsa_SHPRH_0006800 | Exon-Exon | chr6:146215286-146234685 | chr6:145894150-145913549 | 441 nt | 0.4331 |
| hsa_SHPRH_0007100 | Exon-Exon | chr6:146215286-146244921 | chr6:145894150-145923785 | 1293 nt | 0.4215 |
| hsa_chr6_0217600 | Intergenic-Intergenic | chr6:146224385-146224566 | chr6:145903249-145903430 | 182 nt | 0.2692 |
| hsa_SHPRH_0009100 | Exon-Exon | chr6:146240484-146254314 | chr6:145919348-145933178 | 1162 nt | 0.4363 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].